Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Possible influence of CREB1, CREBBP and CREM variants on diagnosis and treatment outcome in patients with schizophrenia.
Crisafulli C, Chiesa A, Han C, Lee SJ, Shim DS, Balzarro B, Andrisano C, Sidoti A, Patkar AA, Pae CU, Serretti A.
Neurosci Lett. 2012 Feb 2;508(1):37-41. Epub 2011 Dec 17.
Related citations
Genetic association between the dopamine D3 receptor gene polymorphism (Ser9Gly) and tardive dyskinesia in patients with schizophrenia: a reevaluation in East Asian populations.
Utsunomiya K, Shinkai T, Sakata S, Yamada K, Chen HI, De Luca V, Hwang R, Ohmori O, Nakamura J.
Neurosci Lett. 2012 Jan 17;507(1):52-6. Epub 2011 Dec 6.
Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia.
Crisafulli C, Chiesa A, De Ronchi D, Han C, Lee SJ, Park MH, Patkar AA, Pae CU, Serretti A.
Neurosci Lett. 2012 Jan 6;506(1):170-4. Epub 2011 Nov 6.
Association of biomarkers and depressive symptoms in schizophrenia.
Noto CS, Gadelha A, Belangero SI, Smith MA, de Aguiar BW, Panizzuti B, Mari Jde J, Gama CS, Bressan RA, Brietzke E.
Neurosci Lett. 2011 Nov 21;505(3):282-5. Epub 2011 Oct 21.
Association study of the frizzled 3 gene with Chinese Va schizophrenia.
Kang C, Zhou L, Liu H, Yang J.
Neurosci Lett. 2011 Nov 14;505(2):196-9. Epub 2011 Oct 19.
Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton transporter, in post-mortem prefrontal cortex from patients with bipolar disorder and schizophrenia.
Gigante AD, Andreazza AC, Lafer B, Yatham LN, Beasley CL, Young LT.
Neurosci Lett. 2011 Nov 7;505(1):47-51. Epub 2011 Oct 4.
TNF-α -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment.
Huang HH, Wang YC, Wu CL, Hong CJ, Bai YM, Tsai SJ, Liou YJ.
Neurosci Lett. 2011 Oct 31;504(3):277-80. Epub 2011 Sep 28.
Association between suicide attempt and a tri-allelic functional polymorphism in serotonin transporter gene promoter in Chinese patients with schizophrenia.
Hung CF, Lung FW, Chen CH, O'Nions E, Hung TH, Chong MY, Wu CK, Wen JK, Lin PY.
Neurosci Lett. 2011 Oct 31;504(3):242-6. Epub 2011 Sep 22.
Neurocognitive effects of first- and second-generation antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up study.
Guo X, Zhai J, Wei Q, Twamley EW, Jin H, Fang M, Hu M, Zhao J; Early-stage Schizophrenia Outcome Study (ESOS) Investigators.
Neurosci Lett. 2011 Oct 3;503(2):141-6. Epub 2011 Aug 24.
Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801.
Roenker NL, Gudelsky G, Ahlbrand R, Bronson SL, Kern JR, Waterman H, Richtand NM.
Neurosci Lett. 2011 Aug 18;500(3):167-71. Epub 2011 Jun 15.
Semantic fluency and executive functions as candidate endophenotypes for the early diagnosis of schizophrenia in Han Chinese.
Hu M, Chen J, Li L, Zheng Y, Wang J, Guo X, Wu R, Zhao J.
Neurosci Lett. 2011 Sep 20;502(3):173-7. Epub 2011 Jul 30.
Decision-making impairment in schizophrenia: relationships with positive symptomatology.
Struglia F, Stratta P, Gianfelice D, Pacifico R, Riccardi I, Rossi A.
Neurosci Lett. 2011 Sep 15;502(2):80-3. Epub 2011 Jul 20.
Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia.
Yang YQ, Sun S, Yu YQ, Li WJ, Zhang X, Xiu MH, Chen da C, De Yang F, Liu H, Li C, Kosten TR, Zhang XY.
Neurosci Lett. 2011 Sep 8;502(1):37-40. Epub 2011 Jul 20.
Increased annexin-V and decreased TNF-alpha serum levels in chronic-medicated patients with schizophrenia.
Francesconi LP, Ceresér KM, Mascarenhas R, Stertz L, Gama CS, Belmonte-de-Abreu P.
Neurosci Lett. 2011 Sep 20;502(3):143-6. Epub 2011 Jun 29.
Neurological Soft Signs and Corpus Callosum morphology in schizophrenia.
Bersani G, Quartini A, Paolemili M, Clemente R, Iannitelli A, Di Biasi C, Gualdi G.
Neurosci Lett. 2011 Jul 25;499(3):170-4. Epub 2011 May 27.
N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder.
Dean OM, van den Buuse M, Berk M, Copolov DL, Mavros C, Bush AI.
Neurosci Lett. 2011 Jul 25;499(3):149-53. Epub 2011 May 20.
Chronic administration of phencyclidine produces decreased sensitivity to mechanical stimulation in the absence of altered affective behavior: Implications for pain processing in schizophrenia.
Boyette-Davis J, Fuchs PN.
Neurosci Lett. 2011 Jul 8;498(2):153-7. Epub 2011 May 8.
Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.
Moreno JL, Holloway T, Albizu L, Sealfon SC, González-Maeso J.
Neurosci Lett. 2011 Apr 15;493(3):76-9. Epub 2011 Jan 27.
No association between the Catechol-O-Methyltransferase (COMT) val158met polymorphism and cognitive improvement following cognitive remediation therapy (CRT) in schizophrenia.
Greenwood K, Hung CF, Tropeano M, McGuffin P, Wykes T.
Neurosci Lett. 2011 Jun 1;496(2):65-9. Epub 2011 Mar 31. Erratum in: Neurosci Lett. 2011 Jul 15;499(1):57.
Impact on schizotypal personality trait of a genome-wide supported psychosis variant of the ZNF804A gene.
Yasuda Y, Hashimoto R, Ohi K, Fukumoto M, Umeda-Yano S, Yamamori H, Okochi T, Iwase M, Kazui H, Iwata N, Takeda M.
Neurosci Lett. 2011 May 20;495(3):216-20. Epub 2011 Mar 30.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on